Daniel Coman1, Lynn Jeanette Savic1, Isabel Schobert1, John Walsh2, Lucas Christoph Adam1, Nina Tritz1, MingDe Lin1,3, Julius Chapiro1, Albert John Sinusas1,4, Todd Constable1, Douglas Rothman1,2, James Duncan1,2, Fahmeed Hyder1,2, and Dana Peters1
1Radiology & Biomedical Imaging, Yale University, New Haven, CT, United States, 2Biomedical Engineering, Yale University, New Haven, CT, United States, 3Visage Imaging, Inc., San Diego, CA, United States, 4Cardiovascular Medicine, Yale University, New Haven, CT, United States
Synopsis
Here we report extracellular pH (pHe) mapping with
BIRDS using TmDOTP5- in normal and VX2 tumors in rabbit liver tissue. Transarterial
chemoembolization (TACE) was performed and the rabbits were scanned without TACE,
or at 1 day and 2 weeks post TACE. The pHe maps show lower pHe in
tumor and tumor edge compared to normal liver. Tumor acidity prior to TACE remain
at 1 day post TACE, but it is almost normalized at 2 weeks post TACE. The
ability to measure pHe in a translational model and compare it with
“normal” tissue improves tumor detection and monitoring of tumor treatment.
Introduction
Hepatocellular carcinoma is the second leading cause of cancer-related
deaths worldwide and incidence and mortality rates continue to rise yearly.1,2 The efficacy of non-surgical therapies remains
limited because the treated lesions and their microenvironment demonstrate
unpredictable biochemical and physiological characteristics that promote
tumorigenesis and reflect the aggressiveness of the tumor.3 Maps of extracellular
pH (pHe) can be measured in vivo using Biosensor Imaging of
Redundant Deviation in Shifts (BIRDS).
BIRDS uses the macrocyclic chelate DOTP8- (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonate))
complexed with paramagnetic thulium (Tm3+) ion, and has been studied
in tumor models in rat brain, on preclinical scanners.4-6 In this work we report pHe mapping with
BIRDS on a 3T clinical scanner in rabbit liver. We measured pHe in normal
and tumor liver tissues in a model of human liver cancer (VX2), which are highly
vascularized and hyper-glycolytic. This tumor model has been previously used for
translational studies involving intra-arterial therapies for liver cancer treatment.7,8Methods
Seventeen New Zealand
white rabbits were surgically implanted
with VX2 tumors9, which were allowed to grow for two weeks to 10-15 mm diameter. Transarterial
chemoembolization (TACE) was performed using an emulsion of ethiodized oil
(Lipiodol, Guerbet) and doxorubicin delivered to tumor by intra-arterial
super-selective injection via the tumor-supplying branch of the hepatic artery. The rabbits
were scanned either without TACE (n=6), 1 day post TACE (n=3), or 2 weeks post TACE
(n=8). A dose of 0.5mmol/kg TmDOTP5- was used to obtain pHe
maps. 15ml of TmDOTP5- was infused at a rate of 0.5ml/min for 30
min. The MR data was obtained on a 3T Prisma scanner (Siemens, Erlangen, Germany)
using a 15 channel RF coil. The T1 VIBE images were obtained using a
FOV of 20x20cm2, 384x384 matrix, 60 slices of 2.5mm thickness,
TR=5.2ms and TE=2.5ms. The BIRDS data was acquired using a 3D GRE chemical
shift imaging (CSI) sequence. Because paramagnetic probes like TmDOTP5-
possess extremely short T1 and T2 relaxation times
(0.1-10ms) and wide bandwidths (±200ppm), a GRE CSI sequence was used (instead
of spin-echo), modified to obtain short TE and TR. Water suppression was achieved
using a dual-band 640µs Shinnar-Le Roux (SLR) RF pulse which selectively
excited the peaks of interest (10kHz bandwidth) on either side of water. The CSI
was acquired with a FOV of 20x20x25cm3, 2197 rectangular encoding
steps, TR=8ms (limited by SAR), 6min acquisition, and reconstructed to 25x25x25
with a voxel resolution of 8x8x10mm3. The pHe was
calculated from the H2, H3 and H6 chemical shifts of TmDOTP5-.4Results
An example of pHe
mapping of rabbit liver with BIRDS is shown in Fig.1.
The CSI signals (red) were overlaid on a T1 VIBE image (Fig.1A). The chemical shifts of H2, H3 and H6
protons of TmDOTP5- (Fig.1B) were
used to calculate the pHe maps (Fig.1C).
Examples of pHe mapping with BIRDS in liver without TACE, at 1 day
and at 2 weeks post TACE are shown in Fig.2.
The T1 VIBE images were used for tumor localization (Fig.2, black)
and to delineate normal liver regions (Fig.2,
blue). BIRDS using the H2, H3 and H6 TmDOTP5- protons (Fig.2, red) was used to generate pHe
maps of liver tumor (Fig.2A, 2C and 2E) and normal
liver (Fig.2B, 2D and 2F). The pHe
maps show a distinctly lower pHe in the tumor and edge areas
compared to normal liver. An average pHe was calculated in each
animal from the CSI voxels located inside the corresponding liver region, at
each time point prior to or post TACE (1 day, and 2 weeks). Fig.3 shows acidity in tumors prior to TACE (pHe=6.80±0.08),
which remain at 1 day post TACE (pHe=6.88±0.04), but it is shifted
towards normalized values at 2 weeks post TACE (pHe=7.02±0.04).
Similar low pHe values were observed at the edge of the tumor, while
in normal liver the pHe values were within the range of 7.1-7.2 at
all time points. Discussion
This work demonstrates for the first time the feasibility of obtaining
pHe maps with BIRDS on a clinical scanner. The results indicate a
low pHe (pHe=6.80±0.08) in the VX2 tumors without TACE. A
gradual increase in time towards pHe normalization was indicated by
the pHe values at 1 day (pHe=6.88±0.04) and 2 weeks (pHe=7.02±0.04)
post TACE. However, these values are still lower than the average pHe
value of normal liver (pHe=7.19±0.03) measured in rabbits without
TACE (Fig.3). In conclusion, the ability to
measure pHe distributions in a translational liver tumor model and to
compare them with “normal” tissue has important implications for tumor
detection, but also for monitoring the efficacy of different liver tumor
treatments. Acknowledgements
This work was supported by NIH (R01 CA206180, R01
EB-023366, P30 NS-052519), by the Society of Interventional Oncology Research
Grant and Visage Imaging, Inc.References
1) J Ferlay, I.S., M Ervik, et al. GLOBOCAN
2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBased No. 11.
2012
2) Njei B1, Rotman Y, Ditah I, Lim JK. Emerging trends in
hepatocellular carcinoma incidence and mortality. Hepatology, 2015. 61(1): p. 191-9.
3)
Hanahan D, Weinberg RA. Hallmarks of cancer: the next
generation. Cell.
2011;144(5):646-74.
4) Coman
D, Trubel HK, Rycyna RE, Hyder F. Brain temperature and pH measured by 1H
chemical shift imaging of a thulium agent. NMR in Biomed 2009;22(2):229-239.
5) Huang
Y, Coman D, Herman P, Rao JU, Maritim S, Hyder F. Towards longitudinal mapping
of extracellular pH in gliomas. NMR Biomed 2016; 29(10): 1364-1372.
6) Coman
D, Huang Y, Rao JU et al. Imaging the intratumoral-peritumoral extracellular pH
gradient of gliomas. NMR Biomed 2016; 29(3): 309-319.
7) Liapi E, Geschwind JF,Vali M, Khwaja AA, Prieto-Ventura V, Bujis M, Vossen J, Ganapathy S, Wahl R.
Assessment of tumoricidal efficacy and response to treatment with 18F–FDG
PET/CT after intra-arterial infusion with the antiglycolytic agent 3-
bromopyruvate in the VX2 model of liver tumor. J. Nucl. Med. 2011;
52(2):225–230.
8)
Duran R, Mirpour S, Pekurovsky V, Ganapathy-Kanniappan
S, Brayton CF, Cornish TC, Gorodetski B, Reyes J, Chapiro J, Schernthaner RE,
Frangakis C, Lin M, Sun JD, Hart CP, Geschwind JF. Preclinical Benefit of
Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer. Clin Cancer Res. 2017 Jan 15;23(2):536-548.
9)
Vali
M, Vossen JA, Buijs M, Engles JM, Liapi E, Ventura VP, Khwaja A, Acha-Ngwodo O,
Ganapathy-Kanniappan S, Syed L, Wahl RL, Geschwind JF. Targeting of VX2 rabbit
liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and
survival study.J Pharmacol Exp Ther. 2008 Oct;327(1):32-7.